Altered regulation of renin-angiotensin, endothelin and natriuretic peptide systems in rat kidney with chronic unilateral ureteral obstruction

Urologia Internationalis

Volumn 79, Issue 2, 2007, Pages 170-176

  Bae, Eun Hui ^a   Kim, In Jin ^a   Park, Jeong Woo ^a   Ma, Seong Kwon ^a   Choi, Ki Chul ^a   Lee, Jong Un ^a   Kim, Soo Wan ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Endothelin; Natriuretic peptide; Renin angiotensin aldosterone system; Transforming growth factor 1; Unilateral ureteral obstruction

Indexed keywords

ALDOSTERONE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN; ENDOTHELIN 1; MESSENGER RNA; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KIDNEY; KIDNEY CORTEX; LIGATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URETER; URETER OBSTRUCTION;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTHELINS; FIBROSIS; KIDNEY; MALE; NATRIURETIC PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; URETERAL OBSTRUCTION;

EID: 34548629415     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106333     Document Type: Article

References (23)

1. Ketteler M, Noble NA, Border WA: Transforming growth factor-β and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol 1995;57:279-295.
2. Stephenson LA, Haney LB, Hussaini IM , Karns LR, Glass WF: Regulation of smooth muscle α-actin expression and hypertrophy in cultured mesangial cells. Kidney Int 1998;54:1175-1187.
3. Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM: Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 1998;31:699-705.
4. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI: Counterregulatory actions of angiotensin-(1-7). Hypertension 1997;30:535-541.
5. Xue C, Siragy HM: Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor. Hypertension 2005;46:584-590.
6. Delyani JA: Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology. Kidney Int 2000;57:1408-1411.
7. Bakris GL, Re RN: Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells. Am J Physiol 1993;264:F937-F942.
8. Wolf G, Ziyadeh FN, Zahner G, Stahl RA: Angiotensin II is mitogenic for cultured rat glomerular endothelial cells. Hypertension 1996;27:897-905.
9. Han B, Hasin Y: Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1. Cardiovasc Drugs Ther 2003;17:41-52.
10. Kim SW, Lee J, Park JW, Hong JH, Kook H, Choi C, Choi KC: Increased expression of atrial natriuretic peptide in the kidney of rats with bilateral ureteral obstruction. Kidney Int 2001;59:1274-1282.
11. Kim SW, Li Y, Kim S, Oh YW, Lee JU: Local renal and vascular natriuretic peptide system in obstructive uropathic rats. Urol Res 2002;30:97-101.
12. Kim SW, Lee JU, Choi KC: Increased expression of atrial natriuretic peptide in ureteral obstructed kidneys in rats. Scand J Urol Nephrol 2001;35:163-168.
13. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-1456.
14. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J: Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001;10:321-329.
15. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993;3:1531-1540.
16. Ruiz-Ortega M, Egido J: Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 1997;52:1497-1510.
17. Obata J, Nakamura T, Takano H, Naito A, Kimura H, Yoshida Y, Shimizu F, Guo DF, Znagami T: Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 2000;18:1247-1255.
18. Ferrario CM, Chappell MC: Novel angiotensin peptides. Cell Mol Life Sci 2004;61:2720-2727.
19. Sato A, Hayashi K, Naruse M, Saruta T: Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension 2003;41:64-68,
20. White PC: Aldosterone: direct effects on and production by the heart. J Clin Endocrinol Metab 2003;88:2376-2383.
21. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, Dewit D, Yanagisawa M: ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994;78:473-485.
22. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
23. Chen HH, Burnett JC Jr: C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 1998;32(suppl 3):S22-S28.